News

A conversation with Joseph Kleiman emphasizes price transparency, consumer research and the need for consistent pricing and drug availability.

A study of older women suggests that greater muscle strength lowers the risk of death, regardless of other factors like sedentary behavior.

A number of recent studies suggests that shingles vaccine has benefits beyond just protecting against shingles.

A multicenter Swedish study finds influenza vaccination during immunotherapy is associated with longer survival, particularly in people being treated for melanoma, without increasing immune-related side effects.

Jessica Vazzaz, a doctoral researcher and tutor in psychology at the University of Sussex, shared that health plans should require large, well-designed randomized trials before covering sonic sleep aids. She added that benefits are likely fair and could vary by individual, making it critical to understand who these tools actually help and under what conditions.

Citing updated scientific evidence, the FDA has revised safety labels for six menopause hormone therapies, removing previous boxed warnings to better reflect current understanding of their risks and benefits for women in early menopause

Real-world China study uses Markov modeling to show surgery may beat radiotherapy on cost per QALY for ESCC, despite higher upfront costs.

New research at Mount Sinai explains how influenza infections increase the risk of heart attack through a specific immune pathway.

GLP-1 drugs boost health but challenge plastic surgery as rapid weight loss triggers facial sag and skin changes, prompting new options and lifestyle guidance.

Aetna Medicaid and the National Association of Community Health Centers have partnered to reduce high blood pressure rates among Medicaid members in select states by expanding community-based care.

A new economic evaluation finds that pairing extended counseling with a brief course of nicotine replacement therapy offers the best value for health systems integrating smoking cessation into lung cancer screening.

A new study finds that the recombinant zoster vaccine was associated with a 51% lower risk of dementia. This was seen across age and racial and ethnic groups, but the risk reduction was stronger in women compared with men.

A conversation with Gil Yosipovitch, M.D., explores why itch worsens at night, how it rivals chronic pain in quality-of-life impact, and why better assessment of nighttime itch and sleep disruption is urgently needed.

Clinicians weigh sonic sleep tools: who benefits, how to use phone-based audio safely and why CBT-I stays first-line for insomnia.

During an investor call, CVS Health executives said the new legislation requiring changes in PBM business practices was manageable, but they expressed some concern about CMS’s Medicare advanced rate notice.

GLP-1 weight-loss drugs can trigger facial fat loss, deepening wrinkles and sagging; experts warn appearance concerns may reduce adherence and affect health outcomes.

A recent analysis shows that most products subject to price reduction under the Inflation Reduction Act have achieved substantial returns on investment by the time of negotiations.

Florida’s planned AIDS Drug Assistance Program cuts could strip more than 16,000 people of life-saving HIV medications, a move Colleen Kelley, M.D., M.P.H., warns will increase illness, deaths and HIV transmission while sowing fear among already vulnerable patients.

A large database analysis finds that survival differences between men and women with metastatic melanoma disappear when patients receive immunotherapy, with the greatest benefit seen in adults older than 45 years.

And amid the ads for Pringles, Pepsi and Ritz crackers, boxer Mike Tyson appears in a MAHA ad inveighing against processed foods.

COVID-19 care disruptions cut U.S. one-year cancer survival, adding 17,390 deaths; see which cancers and groups were hit hardest.

FDA proposes MRD-negative and complete response endpoints to fast-track multiple myeloma drug approvals, pushing deeper molecular results over ORR.

PBM reform has finally made its way through Congress and was signed into law by President Donald Trump. Here are seven things you need to know about the law.

TrumpRx launched as a government-branded, direct-to-consumer discount platform for select brand-name drugs, but critics argue its cash-only savings may be limited, potentially misleading, and less cost-effective over time than traditional insurance or other programs.

Adolescent and young women are far less likely than men to receive HIV prevention medication despite meeting clinical eligibility and facing substantial HIV risk.

And what has it achieved? The meaning and achievements of managed care change with the times, the context, the goals — and in the eyes of the beholders.

Cigna reported 11% revenue growth for 2025. Company executives focused on several key issues in its call with investors: its settlement with the Federal Trade Commission, a transformation announced last year to move to a rebate-free model in pharmacy benefits, and a focus on patient affordability.